215 related articles for article (PubMed ID: 36045196)
1. Cell Cycle-Related Clinical Applications.
Khan MGM; Wang Y
Methods Mol Biol; 2022; 2579():35-46. PubMed ID: 36045196
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting.
Gupta A; Dagar G; Chauhan R; Sadida HQ; Almarzooqi SK; Hashem S; Uddin S; Macha MA; Akil ASA; Pandita TK; Bhat AA; Singh M
Adv Protein Chem Struct Biol; 2023; 135():21-55. PubMed ID: 37061333
[TBL] [Abstract][Full Text] [Related]
3. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.
Lee YM; Sicinski P
Cell Cycle; 2006 Sep; 5(18):2110-4. PubMed ID: 16969111
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targets in cancer treatment: Cell cycle proteins.
Selvaraj C
Adv Protein Chem Struct Biol; 2023; 135():313-342. PubMed ID: 37061336
[TBL] [Abstract][Full Text] [Related]
5. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.
Vermeulen K; Van Bockstaele DR; Berneman ZN
Cell Prolif; 2003 Jun; 36(3):131-49. PubMed ID: 12814430
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions.
Klein MA
Adv Protein Chem Struct Biol; 2020; 121():115-141. PubMed ID: 32312419
[TBL] [Abstract][Full Text] [Related]
7. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.
Zabihi M; Lotfi R; Yousefi AM; Bashash D
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1585-1606. PubMed ID: 35781526
[TBL] [Abstract][Full Text] [Related]
8. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
9. Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
Santo L; Siu KT; Raje N
Semin Oncol; 2015 Dec; 42(6):788-800. PubMed ID: 26615126
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Roskoski R
Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
[TBL] [Abstract][Full Text] [Related]
11. Cancer therapy: targeting cell cycle regulators.
Johansson M; Persson JL
Anticancer Agents Med Chem; 2008 Oct; 8(7):723-31. PubMed ID: 18855574
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
[TBL] [Abstract][Full Text] [Related]
13. Cyclins and related kinases in cancer cells.
Malumbres M
J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
[TBL] [Abstract][Full Text] [Related]
14. Novel potent pharmacological cyclin-dependent kinase inhibitors.
Węsierska-Gądek J; Chamrád I; Kryštof V
Future Med Chem; 2009 Dec; 1(9):1561-81. PubMed ID: 21425979
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer--a review.
Sarita Rajender P; Ramasree D; Bhargavi K; Vasavi M; Uma V
J Recept Signal Transduct Res; 2010 Aug; 30(4):206-13. PubMed ID: 20560705
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
17. Role of cyclins and cyclin-dependent kinases in pluripotent stem cells and their potential as a therapeutic target.
Jirawatnotai S; Dalton S; Wattanapanitch M
Semin Cell Dev Biol; 2020 Nov; 107():63-71. PubMed ID: 32417217
[TBL] [Abstract][Full Text] [Related]
18. Discovery of small molecule degraders for modulating cell cycle.
Wang L; Yang Z; Li G; Liu Y; Ai C; Rao Y
Front Med; 2023 Oct; 17(5):823-854. PubMed ID: 37935945
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
Roskoski R
Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
[TBL] [Abstract][Full Text] [Related]
20. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.
MacLachlan TK; Sang N; Giordano A
Crit Rev Eukaryot Gene Expr; 1995; 5(2):127-56. PubMed ID: 8845581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
